Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Janzon

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Heart (British Cardiac Society)|May 6, 2019
Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarctionDaniel Lindholm, Giovanna Sarno, David Erlinge, et al.
Lakartidningen|November 8, 2022
[Clinical Frailty Scale - a proxy estimate of biological age]Niklas Ekerstad, Tommy Cederholm, Anne-Marie Boström, et al.
Journal of Medical Economics|May 15, 2010
Costs of bleeds relating to acute coronary syndrome therapiesAlexander Bufe, Ferrari Emile, Laurent Drogoul, et al.
Platelets|June 5, 2020
Sex differences in platelet reactivity in patients with myocardial infarction treated with triple antiplatelet therapy - results from assessing platelet activity in coronary heart disease (APACHE)Anna Holm, Eva Swahn, Sofia Sederholm Lawesson, et al.
Kardiologia Polska|March 21, 2012
Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry)Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, et al.
Atherosclerosis|June 5, 2012
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)Artur Dziewierz, Waldemar Mielecki, Zbigniew Siudak, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
American Heart Journal|February 19, 2022
Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary careOlof Persson Lindell, Lars O Karlsson, Staffan Nilsson, et al.
International Journal of Family Medicine|February 1, 2013
Point-of-Care Troponin T Testing in the Management of Patients with Chest Pain in the Swedish Primary CareStaffan Nilsson, Per O Andersson, Lars Borgquist, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Heart (British Cardiac Society)|May 6, 2019
Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarctionDaniel Lindholm, Giovanna Sarno, David Erlinge, et al.
Lakartidningen|November 8, 2022
[Clinical Frailty Scale - a proxy estimate of biological age]Niklas Ekerstad, Tommy Cederholm, Anne-Marie Boström, et al.
Journal of Medical Economics|May 15, 2010
Costs of bleeds relating to acute coronary syndrome therapiesAlexander Bufe, Ferrari Emile, Laurent Drogoul, et al.
Platelets|June 5, 2020
Sex differences in platelet reactivity in patients with myocardial infarction treated with triple antiplatelet therapy - results from assessing platelet activity in coronary heart disease (APACHE)Anna Holm, Eva Swahn, Sofia Sederholm Lawesson, et al.
Kardiologia Polska|March 21, 2012
Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry)Tomasz Rakowski, Zbigniew Siudak, Artur Dziewierz, et al.
Atherosclerosis|June 5, 2012
Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry)Artur Dziewierz, Waldemar Mielecki, Zbigniew Siudak, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
American Heart Journal|February 19, 2022
Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary careOlof Persson Lindell, Lars O Karlsson, Staffan Nilsson, et al.
International Journal of Family Medicine|February 1, 2013
Point-of-Care Troponin T Testing in the Management of Patients with Chest Pain in the Swedish Primary CareStaffan Nilsson, Per O Andersson, Lars Borgquist, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
Pageof 8